Ten Hagen Nele Alexandra, Twele Friederike, Meller Sebastian, Jendrny Paula, Schulz Claudia, von Köckritz-Blickwede Maren, Osterhaus Ab, Ebbers Hans, Pink Isabell, Welte Tobias, Manns Michael Peter, Illig Thomas, Fathi Anahita, Addo Marylyn Martina, Nitsche Andreas, Puyskens Andreas, Michel Janine, Krause Eva, Ehmann Rosina, von Brunn Albrecht, Ernst Christiane, Zwirglmaier Katrin, Wölfel Roman, Nau Alexandra, Philipp Eva, Engels Michael, Schalke Esther, Volk Holger Andreas
Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, Hannover, Germany.
Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
Front Med (Lausanne). 2021 Nov 18;8:749588. doi: 10.3389/fmed.2021.749588. eCollection 2021.
Testing of possibly infected individuals remains cornerstone of containing the spread of SARS-CoV-2. Detection dogs could contribute to mass screening. Previous research demonstrated canines' ability to detect SARS-CoV-2-infections but has not investigated if dogs can differentiate between COVID-19 and other virus infections. Twelve dogs were trained to detect SARS-CoV-2 positive samples. Three test scenarios were performed to evaluate their ability to discriminate SARS-CoV-2-infections from viral infections of a different aetiology. Naso- and oropharyngeal swab samples from individuals and samples from cell culture both infected with one of 15 viruses that may cause COVID-19-like symptoms were presented as distractors in a randomised, double-blind study. Dogs were either trained with SARS-CoV-2 positive saliva samples (test scenario I and II) or with supernatant from cell cultures (test scenario III). When using swab samples from individuals infected with viruses other than SARS-CoV-2 as distractors (test scenario I), dogs detected swab samples from SARS-CoV-2-infected individuals with a mean diagnostic sensitivity of 73.8% (95% CI: 66.0-81.7%) and a specificity of 95.1% (95% CI: 92.6-97.7%). In test scenario II and III cell culture supernatant from cells infected with SARS-CoV-2, cells infected with other coronaviruses and non-infected cells were presented. Dogs achieved mean diagnostic sensitivities of 61.2% (95% CI: 50.7-71.6%, test scenario II) and 75.8% (95% CI: 53.0-98.5%, test scenario III), respectively. The diagnostic specificities were 90.9% (95% CI: 87.3-94.6%, test scenario II) and 90.2% (95% CI: 81.1-99.4%, test scenario III), respectively. In all three test scenarios the mean specificities were above 90% which indicates that dogs can distinguish SARS-CoV-2-infections from other viral infections. However, compared to earlier studies our scent dogs achieved lower diagnostic sensitivities. To deploy COVID-19 detection dogs as a reliable screening method it is therefore mandatory to include a variety of samples from different viral respiratory tract infections in dog training to ensure a successful discrimination process.
对可能感染个体的检测仍然是遏制SARS-CoV-2传播的基石。检疫犬有助于大规模筛查。先前的研究证明了犬类检测SARS-CoV-2感染的能力,但尚未研究犬是否能区分COVID-19和其他病毒感染。训练了12只犬来检测SARS-CoV-2阳性样本。进行了三种测试场景以评估它们区分SARS-CoV-2感染与不同病因病毒感染的能力。在一项随机双盲研究中,将来自感染了15种可能导致类似COVID-19症状的病毒之一的个体的鼻咽拭子样本和细胞培养样本作为干扰物呈现。犬要么用SARS-CoV-2阳性唾液样本(测试场景I和II)训练,要么用细胞培养上清液(测试场景III)训练。当使用来自感染非SARS-CoV-2病毒个体的拭子样本作为干扰物时(测试场景I),犬检测来自SARS-CoV-2感染个体的拭子样本,平均诊断敏感性为73.8%(95%CI:66.0-81.7%),特异性为95.1%(95%CI:92.6-97.7%)。在测试场景II和III中,呈现了来自感染SARS-CoV-2的细胞、感染其他冠状病毒的细胞和未感染细胞的细胞培养上清液。犬分别实现了61.2%(95%CI:50.7-71.6%,测试场景II)和75.8%(95%CI:53.0-98.5%,测试场景III)的平均诊断敏感性。诊断特异性分别为90.9%(95%CI:87.3-94.6%,测试场景II)和90.2%(95%CI:81.1-99.4%,测试场景III)。在所有三种测试场景中,平均特异性均高于90%,这表明犬可以区分SARS-CoV-2感染与其他病毒感染。然而,与早期研究相比,我们的嗅探犬获得了较低的诊断敏感性。因此,要将COVID-19检测犬作为一种可靠的筛查方法部署,必须在犬训练中纳入来自不同病毒性呼吸道感染的各种样本,以确保成功的区分过程。